NCT00559884
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- GSK Investigational Site Columbus, Ohio, United States
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
2,679 public trials
157 recruiting studies
Diabetes Mellitus, Type 2 trial results
NCT00501683
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- GSK Investigational Site Madison, Wisconsin, United States
NCT01610219
- Conditions
- Body Weight, Diabetes Mellitus, Diabetes Mellitus, Type 2, +10 more
- Locations
-
- University of Pennsylvania Center for Weight and Eating Disorders/Perelman School of Medicine Philadelphia, Pennsylvania, United States
Completed
A First-in-Human Study of LY2409021 in Healthy Participants and Participants With Type 2 Diabetes
NCT01606371
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Singapore
NCT01606397
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Singapore
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Plymouth, United Kingdom
NCT01433380
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Pfizer Investigational Site Baton Rouge, Louisiana, United States
NCT00928889
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Dyslipidemias, +6 more
- Locations
-
- People's Liberation Army. The Military General Hospital of BeiJing Beijing, China
- Peiking University First Hospital Beijing, China
- Chinese PLA General Hospital Beijing, China
- The First Affiliated Hospital, Zhongshan (Sun Yat-sen) University Guangzhou, China
NCT01595269
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Calgary Health Region's offices across southwestern Alberta Lethbridge, Alberta, Canada
Completed
A Study to Assess the Effects of Vildagliptin on Gastric Emptying in Patients With Type 2 Diabetes
NCT00351507
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
NCT00099866
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Novartis investigative Site Investigative Sites, Germany